MannKind announced that Steven B. Binder will retire from his position as Chief Financial Officer, effective April 22. Mr. Binder plans to remain at MannKind through the end of the year as Executive Vice President, Special Projects. Christopher Prentiss has been appointed as Chief Financial Officer, effective April 22 …Prentiss will be a member of MannKind’s executive leadership team and will report to Michael Castagna, Chief Executive Officer. “We are excited to have Chris join us at such a pivotal time as our new CFO,” said Michael Castagna, PharmD., Chief Executive Officer for MannKind Corporation. “Chris will be responsible for ensuring we maintain our fiscal discipline as we continue to deleverage the balance sheet and invest behind our growth opportunities in the coming years.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MNKD:
- MannKind Corp Announces CFO Transition and New Compensation Plan
- MannKind Announces CFO Transition
- INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps
- MannKind announces initial meal challenge data from INHALE-3 study
- Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
